This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Emory University, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2021.
Company Filing History:
1 out of 1,022 
1 out of 953 
Years Active: 2021
Title: Cherry Wongtrakool: Innovator in RNA Cleaving Nucleobase Polymers
Introduction
Cherry Wongtrakool is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of biomedical research, particularly in managing inflammatory disorders through innovative technologies. His work focuses on the development of nucleobase polymers that have the potential to transform treatment approaches for various respiratory conditions.
Latest Patents
Wongtrakool holds a patent for "Particles with RNA cleaving nucleobase polymers and uses for managing inflammatory disorders." This patent relates to nucleobase polymers that are effective in degrading GATA-3 mRNA. The technology has promising applications in managing disorders associated with excessive GATA-3 expression, particularly in inflammatory and respiratory disorders such as asthma. He has 1 patent to his name, showcasing his innovative approach to addressing complex health issues.
Career Highlights
Throughout his career, Wongtrakool has worked with prestigious institutions, including Emory University and the United States Government as represented by the Department of Veterans Affairs. His research has been pivotal in advancing our understanding of inflammatory disorders and developing new therapeutic strategies.
Collaborations
Wongtrakool has collaborated with notable colleagues in his field, including Khalid Salaita and Kornelia Galior. These partnerships have enriched his research and contributed to the advancement of innovative solutions in biomedical science.
Conclusion
Cherry Wongtrakool's work exemplifies the impact of innovative research in managing inflammatory disorders. His contributions to the field through his patent and collaborations highlight the importance of continued exploration in biomedical technologies.